Clinical Trials in Massachusetts

Showing 9021-9040 of 13,570 trials

eHealth Partnered Evaluation Initiative

NCT02665468

On October 1, 2016, the VHA Office of Telehealth and the Connected Health Office will merge to create a single entity that will be responsible for the implementation and evaluation of eHealth technologies across the healthcare system. In an effort to successfully fulfill its mission, the new combined Connected Health/Telehealth Office is pledging $1,100,000 for an eHealth Partnered Evaluation Initiative (PEI) to support the further implementation of eHealth technologies across VHA, and to measure their impacts on dimensions of access and other outcomes. Developed in close consultation with leadership of the new office, the proposed objectives of the eHealth PEI are to (1) implement a patient-level "supported adoption intervention" for secure messaging and evaluate the impact of secure messaging use through a rapid, one-year randomized trial; and (2) evaluate the initial rollout of VHA's automated telehealth text messaging system to Veterans and clinical team members.

Non-secure Message Senders

VA Office of Research and Development1,196 participantsStarted Feb 2016

Birmingham, Alabama, United States • Bedford, Massachusetts, United States • Pittsburgh, Pennsylvania, United States +1 more locations

COMPLETEDPhase 326 miles

Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal Metastases

NCT02320825

The purpose of this study is to find out whether giving one higher dose of radiation is as good at treating the tumor in the patient's spine after surgery as giving three lower doses of radiation.

Spinal Metastases

Memorial Sloan Kettering Cancer Center16 participantsStarted Dec 2014

Stanford, California, United States • Baltimore, Maryland, United States • Boston, Massachusetts, United States +1 more locations

eHealth Partnered Evaluation Initiative

Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal Metastases

Find Trials by Condition in Massachusetts

Electronic Medication Adherence Reporting and Feedback During Care Transitions

Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581

Detect Fluid Early From Intra-thoracic Impedance Monitoring

Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry

Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone

Machine Learning to Predict Clinical Response to TMS

Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

Thyroid Therapy for Mild Thyroid Deficiency in Pregnancy

Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS)

Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS)

A Sustainable Approach to Increasing Cancer Screening

Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

GSK1120212 Rollover Study

A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound

A Study to Evaluate the Safety of Aceneuramic Acid Extended Release (Ace-ER; UX001) Tablets in Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy (GNEM) (Also Known as Hereditary Inclusion Body Myopathy [HIBM]) Patients With Severe Ambulatory Impairment

Heart Outcomes Prevention and Evaluation 4